GlassScriptPhysician profile
Kellie Pearson Glover
NPI 1619365103
$1,268.47
in general payments reported to CMS, 2019-2025
11 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $261 · 2022: $320 · 2023: $159 · 2024: $238 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $686.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $511.96 | 2021-2025 | Lifevest |
| Abbott Laboratories | $328.67 | 2023-2025 | Perclose Prostyle, Diamondback Peripheral, Supera |
| Irhythm Technologies, INC. | $133.97 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $93.23 | 2025 | Opticross 6, General - Therapies |
| Astrazeneca Pharmaceuticals LP | $51.55 | 2021-2023 | Farxiga |
| Medtronic, INC. | $38.55 | 2022 | |
| Masimo Corporation | $37.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.10 | 2021 | |
| Angiodynamics, INC. | $18.16 | 2025 | Auryon Laser System 100-120 Vac |
| Pfizer INC. | $17.65 | 2024 | |
| Merck Sharp & Dohme LLC | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellie Glover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.